Skip to main content
Log in

Oral or IM phytomenadione for neonates? The debate continues

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sutor AH. Vitamin K deficiency bleeding in infants and children. Semin Thromb Hemost 1995; 21(3): 317–29

    Article  PubMed  CAS  Google Scholar 

  2. McNinch AW, Upton C, Samuels M, et al. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child 1985; 60(9): 814–8

    Article  PubMed  CAS  Google Scholar 

  3. von Kries R. Oral versus intramuscular Phytomenadione: safety and efficacy compared. Drug Saf 1999 Jul; 21(1): 1–6

    Article  Google Scholar 

  4. Which vitamin K preparation for the newborn? Drug Ther Bull 1998 Mar; 36(3): 17–9

    Google Scholar 

  5. Greer FR, Marshall SP, Foley AL, et al. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997 Jan; 99(1): 88–92

    Article  PubMed  CAS  Google Scholar 

  6. von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993; 69(3): 293–5

    Google Scholar 

  7. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991; 303(6810): 1105–9

    Article  PubMed  CAS  Google Scholar 

  8. von Kries R, Gobel U. Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy. Acta Paediatr 1992; 81(9): 655–7

    Article  Google Scholar 

  9. Ekelund H. Late haemorrhagic disease in Sweden 1987–1988. Acta Paediatr Scand 1991; 80(10): 966–8

    Article  PubMed  CAS  Google Scholar 

  10. Tönz O, Schubiger G. Neonatale vitamin K prophylaxe und vitamin-K-Mangelblutungen in der Schweiz 1986–1988. Schweiz Med Wochenschr 1988; 118: 1747–52

    PubMed  Google Scholar 

  11. Parker L, Cole M, Craft AW, et al. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ 1998; 316(7126): 189–93

    Article  PubMed  CAS  Google Scholar 

  12. Dargaville PA, Campbell NT. Overdose of ergometrine in the newborn infant: acute symptomatology and long-term outcome. J Paediatr Child Health 1998; 34(1): 83–9

    Article  PubMed  CAS  Google Scholar 

  13. Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990; 62: 304–8

    Article  PubMed  CAS  Google Scholar 

  14. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305(6849): 341–6

    Article  PubMed  CAS  Google Scholar 

  15. McKinney PA, Juszczak E, Findlay E, et al. Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K. BMJ 1998; 316(7126): 173–7

    Article  PubMed  CAS  Google Scholar 

  16. Passmore SJ, Draper G, Brownbill P, et al. Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer. BMJ 1998; 316(7126): 184–9

    Article  PubMed  CAS  Google Scholar 

  17. Passmore SJ, Draper G, Brownbill P, et al. Case-control studies of relation between childhood cancer and neonatal vitamin K administration. BMJ 1998; 316(7126): 178–84

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oral or IM phytomenadione for neonates? The debate continues. Drugs Ther. Perspect 14, 14–16 (1999). https://doi.org/10.2165/00042310-199914090-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199914090-00005

Keywords

Navigation